Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ir-Med Inc (IRME)

Ir-Med Inc (IRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 62,977
  • Shares Outstanding, K 69,975
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,910 K
  • 60-Month Beta 1.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IRME with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on 04/01/24
  • Latest Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9000 unch
on 04/26/24
1.4000 -35.71%
on 04/02/24
-0.4040 (-30.98%)
since 03/25/24
3-Month
0.9000 unch
on 04/26/24
1.6500 -45.45%
on 03/05/24
-0.1500 (-14.29%)
since 01/22/24
52-Week
0.1000 +800.00%
on 04/27/23
1.6510 -45.49%
on 06/12/23
+0.5001 (+125.06%)
since 04/26/23

Most Recent Stories

More News
IR-Med Gains Momentum in 2022

/PRNewswire/ -- "IR-MED" or the "Company" (OTCQB:IRME), an innovative medical device company that develops non-invasive, real-time detection devices that...

IRME : 0.9000 (-5.26%)
IR-Med To Initiate Useability Study of its PressureSafe Device

Rosh Pinna, Israel, June 23, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative development stage medical device company...

IRME : 0.9000 (-5.26%)
IR-MED Names Moshe Gerber as New CEO

IR-Med (“ IR-MED or the “ Company ”) ( OTCQB:IRME) , an innovative development-stage medical device company utilizing Infra-Red light spectroscopy (IR) and Artificial Intelligence (AI) technologies...

IRME : 0.9000 (-5.26%)
IR-Med Announces $3.2 Million Private Placement

IR-Med (“ IR-MED or the “ Company ”) ( OTCQB:IRME) , an innovative development stage medical device company that utilizes Infra-Red light spectroscopy (IR) combined with Artificial Intelligence...

IRME : 0.9000 (-5.26%)
Following Its Recent Annual Updates: IR-Med Announces OTCQB Up-listing: “A Significant Achievement for the Company”

IR-Med (“ IR-Med or the “ Company ”) ( OTC:IRME) is pleased to announce that IR-Med has been approved by OTC Markets to up-list from Pink Sheet to the OTCQB tier after IR-Med satisfied the required...

IRME : 0.9000 (-5.26%)
IR-Med to Announce 2022 Goals: Anticipated POC Results, File for FDA Clearance and up Listing to the OTCQB

IR-Med (OTC: IRME) (“Company” or “the Company”) is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company. Amongst...

IRME : 0.9000 (-5.26%)
IRME Letter to Shareholders

New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m...

OTC.VN : 0.300 (-7.69%)
IRME : 0.9000 (-5.26%)
IR-Med to Become Fully Reporting SEC Company

IR-Med filed an application to uplist to OTCQB New York, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME), a development stage...

OTC.VN : 0.300 (-7.69%)
IRME : 0.9000 (-5.26%)
IR-Med, Inc. Announces the Appointment of Dr. Rom Eliaz as Chief Executive Officer

New York, NY, June 25, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME) announced today the appointment of Dr. Rom Eliaz as Chief Executive Officer.

IRME : 0.9000 (-5.26%)
IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer

New York, NY, April 08, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc, (OTCPink: IRME) (the “Company” or “IR-Med”) announced today the resignation of Limor Davidson Mund as Chief Executive Officer. Ms....

IDAD : 1.5600 (+0.65%)
IRME : 0.9000 (-5.26%)

Business Summary

IR Med Inc. is a development stage company currently focused on the development and application of Infra-Red and Artificial Intelligence technologies to address common medical ailments. The company's technologies are designed to address the early detection of pressure injuries and the detection and diagnosis...

See More

Key Turning Points

3rd Resistance Point 0.9833
2nd Resistance Point 0.9667
1st Resistance Point 0.9333
Last Price 0.9000
1st Support Level 0.8833
2nd Support Level 0.8667
3rd Support Level 0.8333

See More

52-Week High 1.6510
Fibonacci 61.8% 1.0585
Last Price 0.9000
Fibonacci 50% 0.8755
Fibonacci 38.2% 0.6925
52-Week Low 0.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar